276 related articles for article (PubMed ID: 9118816)
1. A practical guide to the recognition and management of myasthenia gravis.
Evoli A; Batocchi AP; Tonali P
Drugs; 1996 Nov; 52(5):662-70. PubMed ID: 9118816
[TBL] [Abstract][Full Text] [Related]
2. Myasthenia gravis: signs, symptoms, diagnosis, immunology, and current therapy.
Scheife RT; Hills JR; Munsat TL
Pharmacotherapy; 1981; 1(1):39-54. PubMed ID: 6927602
[TBL] [Abstract][Full Text] [Related]
3. Myasthenia gravis. Pathogenesis and current concepts in management.
Havard CW; Scadding GK
Drugs; 1983 Aug; 26(2):174-84. PubMed ID: 6884241
[TBL] [Abstract][Full Text] [Related]
4. [Myasthenia gravis].
Fleury MC; Tranchant C
Rev Prat; 2008 Dec; 58(20):2217-24. PubMed ID: 19209651
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppressive treatment of ocular myasthenia gravis.
Tackenberg B; Hemmer B; Oertel WH; Sommer N
BioDrugs; 2001; 15(6):369-78. PubMed ID: 11520248
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic strategies for myasthenia gravis.
Keys PA; Blume RP
DICP; 1991 Oct; 25(10):1101-8. PubMed ID: 1803801
[TBL] [Abstract][Full Text] [Related]
7. Overview of myasthenia gravis.
Arora Y; Li Y
Hosp Pract (1995); 2013; 41(4):40-50. PubMed ID: 24145588
[TBL] [Abstract][Full Text] [Related]
8. Ocular myasthenia gravis: response to long-term immunosuppressive treatment.
Sommer N; Sigg B; Melms A; Weller M; Schepelmann K; Herzau V; Dichgans J
J Neurol Neurosurg Psychiatry; 1997 Feb; 62(2):156-62. PubMed ID: 9048716
[TBL] [Abstract][Full Text] [Related]
9. Myasthenia gravis: clinical features, pathogenesis, evaluation, and medical management.
Heitmiller RF
Semin Thorac Cardiovasc Surg; 1999 Jan; 11(1):41-6. PubMed ID: 9930711
[TBL] [Abstract][Full Text] [Related]
10. [Myasthenia in elderly patients: a series of 23 cases].
Durand F; Camdessanché JP; Jomir L; Antoine JC; Cathébras P
Rev Med Interne; 2005 Dec; 26(12):924-30. PubMed ID: 16229927
[TBL] [Abstract][Full Text] [Related]
11. Management of myasthenia gravis.
Schwendimann RN; Burton E; Minagar A
Am J Ther; 2005; 12(3):262-8. PubMed ID: 15891271
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive therapies in myasthenia gravis.
Sanders DB; Evoli A
Autoimmunity; 2010 Aug; 43(5-6):428-35. PubMed ID: 20166870
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and prognosis of myasthenia gravis in older people.
Evoli A; Batocchi AP; Minisci C; Di Schino C; Tonali P
J Am Geriatr Soc; 2000 Nov; 48(11):1442-8. PubMed ID: 11083321
[TBL] [Abstract][Full Text] [Related]
14. Juvenile myasthenia: diagnosis and treatment.
Anlar B
Paediatr Drugs; 2000; 2(3):161-9. PubMed ID: 10937467
[TBL] [Abstract][Full Text] [Related]
15. New treatment approaches to myasthenia gravis.
Havard CW; Fonseca V
Drugs; 1990 Jan; 39(1):66-73. PubMed ID: 2178913
[TBL] [Abstract][Full Text] [Related]
16. [Peripheral nervous system immunological disorder].
Erazo Torricelli R
Medicina (B Aires); 2018; 78 Suppl 2():82-87. PubMed ID: 30199371
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity.
Meriggioli MN; Sanders DB
Lancet Neurol; 2009 May; 8(5):475-90. PubMed ID: 19375665
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of autoimmune myasthenia].
Pénisson-Besnier I
Rev Neurol (Paris); 2010 Apr; 166(4):400-5. PubMed ID: 19836041
[TBL] [Abstract][Full Text] [Related]
19. [Myasthenia gravis - optimal treatment and accurate diagnosis].
Gilhus NE; Kerty E; Løseth S; Mygland Å; Tallaksen C
Tidsskr Nor Laegeforen; 2016 Jul; 136(12-13):1089-94. PubMed ID: 27381787
[TBL] [Abstract][Full Text] [Related]
20. Myasthenia Gravis and Congenital Myasthenic Syndromes.
Ciafaloni E
Continuum (Minneap Minn); 2019 Dec; 25(6):1767-1784. PubMed ID: 31794470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
